[1] Brito-Zerón P, Retamozo S, Ramos-Casals M. Sjgren syndrome[J]. Med Clin, 2023, 160(4): 163-171.
[2] Zhang X L, Yun J S, Han D, et al. TGF-β pathway in salivary gland fibrosis[J]. Int J Mol Sci, 2020, 21(23): 9138.
[3] Sun Y, Zhang W C, Li B S, et al. The coexistence of sjögren's syndrome and primary biliary cirrhosis: a comprehensive review[J]. Clin Rev Allergy Immunol, 2015, 48(2): 301-315.
[4] Kazmi A, Abbas Z, Saleem Z, et al. Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study[J]. BMJ Open, 2022, 12(12): e060738.
[5] Alam J, Lee A, Lee J, et al. Dysbiotic oral microbiota and infected salivary glands in Sjögren's syndrome[J]. PLoS One, 2020, 15(3): e0230667.
[6] Multhoff G, Molls M, Radons J. Chronic inflammation in cancer development[J]. Front Immunol, 2011, 2: 98.
[7] Kamangar F, Dores G M, Anderson W F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14): 2137-2150.
[8] McDermott J D, Bowles D W. Epidemiology of head and neck squamous cell carcinomas: impact on staging and prevention strategies[J]. Curr Treat Options Oncol, 2019, 20(5): 43.
[9] Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer[J]. Technol Cancer Res Treat, 2019, 18: 1533033819867354.
[10] De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases[J]. Clin Exp Immunol, 2019, 195(1): 74-85.
[11] Gissi D B, Asioli S, Gabusi A. Two unusual cases of oral lichen planus arising after oral squamous cell carcinoma: can oral cancer trigger autoimmunity?[J]. Int J Surg Pathol, 2017, 25(5): 443-448.
[12] Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins[J]. J Mol Biol, 2006, 359(3): 509-525.
[13] Yang D Z, Kedei N, Li L W, et al. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype[J]. Cancer Res, 2010, 70(20): 7905-7917.
[14] Stone J C. Regulation and function of the RasGRP family of Ras activators in blood cells[J]. Genes Cancer, 2011, 2(3): 320-334.
[15] Coughlin J J, Stang S L, Dower N A, et al. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling[J]. J Immunol, 2005, 175(11): 7179-7184.
[16] Jun J E, Rubio I, Roose J P. Regulation of ras exchange factors and cellular localization of ras activation by lipid messengers in T cells[J]. Front Immunol, 2013, 4: 239.
[17] Raphael I, Joern R R, Forsthuber T G. Memory CD4+ T cells in immunity and autoimmune diseases[J]. Cells, 2020, 9(3): 531.
[18] Jin Y, Wang Z W, Tang W Z, et al. An integrated analysis of prognostic signature and immune microenvironment in tongue squamous cell carcinoma[J]. Front Oncol, 2022, 12: 891716.
[19] Lu X X, Li N, Zhao L, et al. Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype[J]. Exp Eye Res, 2020, 191: 107905.
[20] Yang S, Zhao M, Jia S J. Macrophage: key player in the pathogenesis of autoimmune diseases[J]. Front Immunol, 2023, 14: 1080310.
[21] Moreno-Nieves U Y, Tay J K, Saumyaa S, et al. Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment[J]. Proc Natl Acad Sci U S A, 2021, 118(28): e2101169118.
[22] Chi H, Xie X X, Yan Y J, et al. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC[J]. Front Immunol, 2022, 13: 1018685.
[23] Harvey D, Pointon J J, Sleator C, et al. Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis[J]. Ann Rheum Dis, 2009, 68(4): 595-598.
[24] Oei V Y S, Siernicka M, Graczyk-Jarzynka A, et al. Intrinsic functional potential of NK-Cell subsets constrains retargeting driven by chimeric antigen receptors[J]. Cancer Immunol Res, 2018, 6(4): 467-480.
[25] Xie G Z, Dong H, Liang Y, et al. CAR-NK cells: A promising cellular immunotherapy for cancer[J]. EBioMedicine, 2020, 59: 102975.
[26] Romee R, Schneider S E, Leong J W, et al. Cytokine activation induces human memory-like NK cells[J]. Blood, 2012, 120(24): 4751-4760.
[27] Laskowski T J, Biederstädt A, Rezvani K. Natural killer cells in antitumour adoptive cell immunotherapy[J]. Nat Rev Cancer, 2022, 22(10): 557-575.
|